S. no | Author | Year of publication | Age | Affected side | Tumor size (cm) | S. tumor markers | Stage | Long term outcomes | Adjuvant treatment |
---|---|---|---|---|---|---|---|---|---|
1 | Hachi | 2002 | 70 | Left | – | Normal | 1 | No recurrence No metastasis | None |
2 | Takizawa | 2005 | 76 | Left | 7.4 | Normal | 1 | No recurrence No metastasis | None |
3 | Raspollini | 2009 | 77 | Left | 4 | Normal | 1 | No recurrence No metastasis | None |
4 | Yoshimine | 2009 | 73 | left | 20 | High BHCG | 3 | Multiple metastasis: lungs- lymphatic, spleen, muscles, spinal | Chemotherapy (CYVADIC) |
5 | Labanaris | 2010 | 73 | Right | 3.5 | Normal | 1 | No recurrence No metastasis | None |
6 | Tobe | 2010 | 71 | Right | Unknown | Normal | 1 | No recurrence No metastasis | None |
7 | Komeya | 2012 | 70 | Left | 4.5 | Normal | 1 | Retroperitoneal metastasis | Radiotherapy |
9 | Hmida | 2014 | 78 | Right | 9 | High LDH levels | 2 | No recurrence No metastasis | None |
10 | Rajagopal | 2017 | 70 | Right | 4 | Normal | 2 | Local recurrence No metastasis | Radiotherapy + wide local excision |
11 | Our case | 2022 | 70 | Left | 10.9 | Normal | 1 | Localized | Â |